搜尋
Femasys Inc
FEMY添加自選
4.170USD
-0.180-4.14%
收盤 07/02, 13:00（美東）報價延遲15分鐘
12.59M總市值
虧損本益比TTM
查看詳細走勢圖
TradingKey 图表盤中分時
1分
30分
1小時
日k
週k
月k
日k
今天
-4.14%
5天
+9.74%
1月
+1067.41%
6月
+617.60%
今年開始到現在
+623.71%
1年
+347.76%
關鍵數據
4.415今開
4.780最高
65.42K成交量
虧損本益比TTM
虧損本益比動
--股利TTM
2.17%換手率
4.350昨收
4.170最低
185.71K成交額
虧損本益比靜
1.73市淨率
0.00%股息率 TTM
-79.84%ROA
1.34052週最高
2.36量比
-18.82M淨利潤
3.02M總股本
-0.2238每股盈餘TTM
-2.13Beta
-255.96%ROE
0.30752週最低
14.02%振幅
43.31%毛利率
12.59M總市值
148.56回報/風險
7.52%風險率
TradingKey Femasys Inc股票評分
單位: USD 更新時間: 2026-07-02操作建議
Femasys Inc當前公司基本面數據相對健康，增長潛力較大。當前估值合理，在醫療設備與耗材行業排名110/204位。機構持股佔比非常高，近一月多位分析師給出公司評級為買入。最高目標價為63.33。中期看，股價處於上升通道。近一個月，市場表現很強，技術面評分較高，但很強的走勢沒有得到基本面的印證。目前股價在壓力位和支撐位之間，可以做區間波段操作。
Femasys Inc評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
中性
Femasys Inc亮點
亮點風險
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.
業績高增長
公司營業收入穩步增長，連續3年增長113.93%
業績增長期
公司處於發展階段，最新年度總收入2.29M美元
利潤高增長
公司淨利潤處於行業前列，最新年度總收入2.29M美元
估值低估
公司最新PE估值-18.63，處於3年歷史低位
機構加倉
最新機構持股6.18M股，環比增加16.17%
活躍度降低
近期活躍度降低，過去20天平均換手率-0.83
分析師目標
基於
3
分析師
買入
評級
63.333
目標均價
+1418.79%
漲幅空間
Femasys Inc新聞
即將為您帶來更多新聞，敬請期待。 。 。
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Femasys Inc簡介
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.
公司代碼FEMY
公司Femasys Inc
CEOLee-Sepsick (Kathy)
網址https://www.femasys.com/
相關品種
-0.37%
+1.91%
+3.48%
+5.87%
+2.10%
-0.10%
+4.19%
+5.03%
+4.30%
+0.25%
+3.65%
+4.74%
+2.79%
+2.59%
-3.06%
+3.40%
+3.76%
+1.10%
+0.28%
-2.09%熱門品種
52901.500
+48.600 (+0.09%)
29752.900
+83.000 (+0.28%)
7517.900
+10.100 (+0.14%)
14977.000
+14.000 (+0.09%)
69788.000
+112.000 (+0.16%)
6414.700
+2.300 (+0.04%)
68.262
-0.421 (-0.61%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4189.450
+14.840 (+0.35%)
常見問題
Femasys Inc(FEMY)的當前股價是多少？
Femasys Inc(FEMY)的當前股價是 4.17。
Femasys Inc 的股票代碼是什麼？
Femasys Inc的股票代碼是FEMY。
Femasys Inc股票的52週最高點是多少？
Femasys Inc股票的52週最高點是1.34。
Femasys Inc股票的52週最低點是多少？
Femasys Inc股票的52週最低點是0.31。
Femasys Inc的市值是多少？
Femasys Inc的市值是248.54M。
現在Femasys Inc(FEMY)的股票是買入、持有還是賣出？
根據分析師評級，Femasys Inc(FEMY)的總體評級為買入，目標價格為63.33。